ABSTRACT
OBJECTIVES: To determine the prevalence of intra- and extra-articular sacroiliac joint (SIJ) pain, which injection is more beneficial, and whether fluoroscopy improves outcomes. PATIENTS AND METHODS: This patient- and evaluator-blinded comparative effectiveness study randomized 125 participants with SIJ pain from April 30, 2014, through December 12, 2017, to receive fluoroscopically guided injections into the joint capsule (group 1) or "blind" injections to the point of maximum tenderness using sham radiographs (group 2). The primary outcome was average pain on a 0 to 10 scale 1 month after injection. A positive outcome was defined as at least a 2-point decrease in average pain score coupled with positive (>3) satisfaction on a Likert scale from 1 to 5. RESULTS: For the primary outcome, no significant differences were observed between groups (mean ± SD change from baseline, -2.3±2.4 points in group 1 vs -1.7±2.3 points in group 2; 95% CI, -0.33 to 1.36 points for adjusted difference; P=.23), nor was there a difference in the proportions of positive blocks (61% vs 62%) or 1-month categorical outcome (48% vs 40% in groups 1 and 2, respectively; P=.33). At 3 months, the mean ± SD reductions in average pain (-1.8±2.1 vs -0.9 ± 2.0 points; 95% CI, 0.11 to 1.58 points for adjusted difference; P=.02) and worst pain (-2.2±2.5 vs -1.4±2.0 points; 95% CI, 0.01 to 1.66 points for adjusted difference; P=.049) were greater in group 1 than 2, with other outcome differences falling shy of statistical significance. CONCLUSION: Although fluoroscopically guided injections provide greater intermediate-term benefit in some patients, these differences are modest and accompanied by large cost differences. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02096653.
Subject(s)
Anesthetics, Local/administration & dosage , Arthritis/diagnostic imaging , Arthritis/drug therapy , Injections, Intra-Articular/methods , Low Back Pain/drug therapy , Low Back Pain/therapy , Sacroiliac Joint/pathology , Adult , Anti-Inflammatory Agents/administration & dosage , Double-Blind Method , Female , Fluoroscopy , Humans , Male , Middle Aged , Pain Measurement/methods , Sacroiliac Joint/diagnostic imaging , Sacroiliac Joint/drug effectsABSTRACT
BACKGROUND: Nephrolithiasis is a common medical condition among aviation personnel that can negatively impact their health and careers. Due to the potentially severe consequences of in-flight renal colic associated with nephrolithiasis, current Navy regulations stipulate extensive evaluation for any aircrew member who has an instance of kidney stones. CASE REPORT: Two cases of Naval aircrew members with kidney stones are reviewed and current Navy standards regarding nephrolithiasis are discussed. DISCUSSION: Current Navy standards for granting aeromedical waivers for kidney stones do not differentiate between pilots in actual control of the aircraft and other aircrew members among aircraft personnel. Furthermore, a premium is placed on stone-free status, even for asymptomatic, incidentally found nephroliths. This policy has many similarities, but also significant differences from those of other services and those of civilian aviation authorities. This difference in protocols across aviation communities should be re-examined in order to promote more efficient return to flying duties of operational personnel without compromising safety of flight.
